GlassScriptPhysician profile
Herbert Paul Knauf
NPI 1396774501
$6,498.30
in general payments reported to CMS, 2019-2025
22 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,313 · 2020: $302 · 2021: $143 · 2022: $358 · 2023: $256 · 2024: $3,624 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,698 · Travel and Lodging: $1,685.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,698.34 |
| Travel and Lodging | $1,684.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $1,769.04 | 2024 | Iolmaster 700, Veracity Surgical, Cirrus Hd-Oct |
| Ivantis, INC | $506.23 | 2019-2021 | |
| Rxsight INC | $429.29 | 2021-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Bausch & Lomb Americas INC. | $339.36 | 2024-2025 | Vyzulta, Miebo, Xiidra |
| Harrow Eye, LLC | $321.43 | 2024 | Iheezo |
| Ocular Therapeutix, INC. | $299.96 | 2021-2024 | Dextenza |
| Nova Eye, INC. | $291.35 | 2024 | |
| Glaukos Corporation | $275.76 | 2024 | Istent Trabecular Micro-Bypass System Model Is3, Idose |
| Alcon Vision LLC | $270.40 | 2019-2024 | |
| Tarsus Pharmaceuticals, INC. | $264.96 | 2024-2025 | Xdemvy |
| Allergan, INC. | $256.86 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $210.91 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $177.08 | 2019 | |
| Mallinckrodt Hospital Products INC. | $146.62 | 2025 | Acthar |
| Dompe US, INC. | $144.84 | 2019-2025 | Oxervate |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $141.97 | 2020 | |
| Aerie Pharmaceuticals, INC. | $139.54 | 2019 | |
| Kala Pharmaceuticals, INC. | $138.91 | 2019 | |
| Sun Pharmaceutical Industries INC. | $124.50 | 2019 | |
| Sight Sciences, INC. | $120.15 | 2022 | |
| Horizon Therapeutics Plc | $112.95 | 2022 | |
| Eyepoint US, INC. | $16.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Knauf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.